Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 61/076,221, filed Jun 27, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,729,018 | Therapeutic Agents Comprising Elastic Peptides In force · High confidence UsedRemaining | Duke University | In force | High confidence | ||
| US 9,328,154 | Therapeutic Agents Comprising Fusions of Growth Hormone and Elastic Peptides In force · High confidence | Duke University | In force | High confidence | ||
| US 9,458,218 | Therapeutic Agents Comprising Fusions of Insulin and Elastic Peptides In force · High confidence | Duke University | In force | High confidence | ||
| US 10,258,700 | Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties In force · Medium confidence | Duke University | In force | Medium confidence | ||
| US 8,841,255 | Therapeutic Agents Comprising Fusions of Vasoactive Intestinal Peptide and Elastic Peptides In force · High confidence | Duke University | In force | High confidence | ||
| US 8,334,257 | Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties In force · High confidence | Duke University | In force | High confidence | ||
| US 8,178,495 | Therapeutic Agents Comprising a GLP-1 Receptor Agonist and Elastin-Like Peptide In force · High confidence | Duke University | In force | High confidence | ||
| US 9,127,047 | Therapeutic Agents Comprising Insulin and Elastin-Like Peptides In force · High confidence | Duke University | In force | High confidence | ||
| US 9,821,036 | Therapeutic Agents Comprising a GLP-2 Peptide and Elastin-Like Peptides In force · High confidence | Duke University | In force | High confidence | ||
| US 10,596,230 | Methods of Increasing Nutrient Absorption in the Intestine Using Therapeutic Agents Comprising GLP-2 and Elastin-Like Peptides In force · Medium confidence | Duke University | In force | Medium confidence | ||
| 8 more records in this group · Pro | ||||||
10 of 18 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 18, including 5 expiring within the 18 months from Nov 20, 2026.
12 of these are in force and held by Duke University.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.